Programme 2022
Day 1
08:15
Registration, coffee, networking
09:00
Welcome
Cécile Oury
STATE OF THE ART I – Future Directions in Platelet Research
Chairs: Cécile Oury and Sandrine Horman
09:15
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis – Interplay between platelets and coagulation
Jonathan Douxfils (Namur, Belgium)
09:35
Linking platelet lipidomics and functions: The way to novel diagnostic and therapeutic opportunities
Robert Ahrends (Vienna, Austria)
09:55
Newest insights and future research opportunities in the field of procoagulant platelets
Claudia Tersteeg (Kortrijk, Belgium)
SPONSORED SATELLITE SYMPOSIUM I (Novo Nordisk)
Chairs: Cédric Hermans
10:15
Clinical outcomes from Early use of N9-GP compared with previous treatment in patients with Haemophilia B
Davide Matino (Hamilton, Canada)
10:45
Choosing optimal treatment using an integrative patient-oriented approach
Cedric Hermans (Brussels, Belgium)
11:15
Coffee Break
SELECTED ORAL PRESENTATIONS – BASIC RESEARCH
Chairs: Karen Vanhoorelbeke and Simon Demeyer
11:45
Ticagrelor prevents Staphylococcus aureus infective endocarditis by mitigating bacterial virulence
Kirsten Leeten (University of Liège)
12:00
DNase-1 can overcome rt-PA resistance of platelet-rich ischemic stroke thrombi
Sarah Vandelanotte (KU Leuven - Kulak Kortrijk)
12:15
Deep vein thrombosis generates a systemic environment promoting release of neutrophil extracellular traps and detrimental cardiac remodeling
Stijn Van Bruggen (KU Leuven)
12:30
α1AMP-activated protein kinase (α1AMPK) regulates hemostatic dysfunctions during septic shock
Julien De Poortere (UCLouvain, Brussels)
12:45
PAUL CAPEL PRIZE - BASIC RESEARCH
13:00
Lunchbreak
13:00
POSTER WALK
EDUCATIONAL I
Chairs: Katrien Devreese and Laure Gilis
14:00
ONLINE | Comprehensive phenotyping of human platelets by single‐cell cytometry
A. Frelinger (Boston Children's Hospital, United States)
SPONSORED SATELLITE SYMPOSIUM II (Sobi Belux)
Chairs: Timothy Devos (UZ Leuven, Leuven) and Dries Deeren (AZ Delta, Roeselare)
14:45
PNH: current treatment options and remaining challenges
Nicole Straetmans (Cliniques Universitaires St-Luc, Brussels)
15:15
Results of the C3 inhibitor Pegcetacoplan in PNH
Louis Terriou (CHRU de Lille - Hôpital Claude Huriez, Lille)
15:45
Coffee Break
PROFESSOR GASTON BAELE MEMORIAL LECTURE
Chairs: Christelle Orlando and Cécile Oury
16:15
Antithrombin, not just an old molecule
Kristin Jochmans
17:00
BSTH GENERAL ASSEMBLY
17:30
CLOSURE OF DAY PROGRAMME
17:30
Reception
19:00
Dinner
Day 2
08:30
Registration, coffee, networking
EDUCATIONAL II
Chairs: Kristel Vandenbosch and Phu Quoc Le
09:00
Acquired TTP diagnosis
Katrien Devreese (UZ Ghent, Belgium)
SPONSORED SATELLITE SYMPOSIUM III (CSL Behring)
Chairs: Peter Verhamme (University Hospitals Leuven) and Veerle Mondelaers (University Hospital Gent)
09:45
Gene therapy in hemophilia, from theory to reality
Cedric Hermans (Université Catholique de Louvain Saint-Luc) and
Michiel Coppens (University Medical Center Amsterdam)
10:45
CSL BEHRING ENCOURAGEMENT AWARD
11:00
Coffee Break
SELECTED ORAL PRESENTATIONS – CLINICAL AND LABORATORY
Chairs: Christelle Orlando and Jan Emmerechts
11:30
Heparin monitoring in ImpellaTM-supported cardiogenic shock patients: parallel dual testing in critically ill
Charlotte Van Edom (UZ Leuven, KULeuven)
11:45
Position of Next Generation Sequencing Testing in the Diagnostic Algorithm of Inherited Thrombophilia
Christine Van Laer (UZ Leuven)
12:00
Genotype-phenotype correlation in Belgian patients with inherited Protein C deficiency
Sandrine Bouteille (UZ Brussels)
12:15
Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: the DAWn-Antico study
Matthias Engelen (UZ Leuven)
12:30
PAUL CAPEL PRIZE – CLINICAL AND LABORATORY
12:45
Lunchbreak
12:45
POSTER WALK
STATE OF THE ART II: In and Beyond Atherothrombosis
Chairs: Thomas Vanassche and Marie Moonen
14:00
Coronary artery disease: Progress in antiplatelet therapy
Lina Badimon (Barcelona, Spain)
14:20
Antithrombotic therapy and Covid-19
Mattias Engelen (Leuven, Belgium)
14:40
Platelets in chronic liver disease
Marie-Astrid Van Dievoet (Brussels, Belgium)
15:00
CLOSING REMARKS